Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Mineralys Therapeutics Inc (MLYS)

Mineralys Therapeutics Inc (MLYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 627,089
  • Shares Outstanding, K 49,769
  • Annual Sales, $ 0 K
  • Annual Income, $ -71,900 K
  • EBIT $ -168 M
  • EBITDA $ -168 M
  • 60-Month Beta 1.71
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.70

Options Overview Details

View History
  • Implied Volatility 130.17% ( -39.68%)
  • Historical Volatility 71.45%
  • IV Percentile 79%
  • IV Rank 64.68%
  • IV High 194.45% on 08/23/24
  • IV Low 12.44% on 11/21/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 20
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 0.74
  • Today's Open Interest 293
  • Open Int (30-Day) 263

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -1.00
  • Number of Estimates 4
  • High Estimate -0.68
  • Low Estimate -1.17
  • Prior Year -0.61
  • Growth Rate Est. (year over year) -63.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.30 +5.75%
on 11/19/24
15.25 -21.64%
on 11/06/24
-1.88 (-13.59%)
since 10/21/24
3-Month
10.92 +9.43%
on 08/22/24
15.25 -21.64%
on 11/06/24
+0.81 (+7.27%)
since 08/21/24
52-Week
5.85 +104.27%
on 11/22/23
16.91 -29.31%
on 02/27/24
+5.93 (+98.50%)
since 11/21/23

Most Recent Stories

More News
Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

MLYS : 11.87 (-5.79%)
Mineralys Therapeutics to Participate in Upcoming Investor Conferences

MLYS : 11.87 (-5.79%)
Mineralys Therapeutics to Announce Third Quarter 2024 Financial Results and Host Conference Call on Monday, November 11, 2024

MLYS : 11.87 (-5.79%)
Mineralys Therapeutics Completes Enrollment Ahead of Schedule in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension

MLYS : 11.87 (-5.79%)
Mineralys to Host Virtual KOL Event on the Unmet Medical Need in Uncontrolled and Resistant Hypertension, and Lorundrostat as a Potential Treatment on October 30, 2024

MLYS : 11.87 (-5.79%)
There's a Lot to Love About Mineralys' Valentine's Day IPO

MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 million

MLYS : 11.87 (-5.79%)
AZN : 64.26 (+1.68%)
CINC : 29.06 (-0.48%)
GPCR : 30.10 (-7.98%)

Business Summary

Mineralys Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Mineralys Therapeutics Inc. is based in RADNOR, Pa.

See More

Key Turning Points

3rd Resistance Point 13.85
2nd Resistance Point 13.45
1st Resistance Point 13.03
Last Price 11.87
1st Support Level 12.20
2nd Support Level 11.80
3rd Support Level 11.38

See More

52-Week High 16.91
Fibonacci 61.8% 12.68
Last Price 11.87
Fibonacci 50% 11.38
Fibonacci 38.2% 10.07
52-Week Low 5.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar